Overall, our data show that, depending on cancer type, TOP1 poisons have immunostimulatory effects mainly due to the STING/cGAS signalling pathway, although potential immunotherapy protocols should be carefully evaluated as SCLC may downregulate the pathway abolishing the drug-triggered immunomodulating activity. This evidence concerns the gene CGAS and small cell lung carcinoma.